SCHEMBL24916541

SCHEMBL24916541

CCc1cc(COC)c2nc(C)cc(C(C)CCN3CCN(c4cc(CC)cc5c(C(C)CCN6CCN(c7cc(OC)cc8c(C(C)C)cc(C)nc78)CC6)cc(C)nc45)CC3)c2c1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.34
HTR2C P28335 2/20 0.34
HTR7 P34969 2/20 0.34
HTR1A P08908 6/20 0.33
DRD2 P14416 4/20 0.33
DRD4 P21917 4/20 0.33
DRD3 P35462 4/20 0.33
OPRM1 P35372 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ADRA1D P25100 2/20 0.30
ADRA1A P35348 2/20 0.30
ADRA1B P35368 2/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24916535 0.78 HTR1A (0.32) HTR1A
SCHEMBL24916056 0.77 KDM4E (0.34) L3MBTL1HPGDMAPT
SCHEMBL24916055 0.75 DRD2 (0.41) HTR2AHTR2CHTR7HTR1ADRD2
SCHEMBL24916054 0.75 HTR1B (0.41) HTR1AHPGDMEN1KMT2A
SCHEMBL24916025 0.74 ELANE (0.38) HTR2AHTR2CHTR7HTR1ADRD2
SCHEMBL24916407 0.72 GPR4 (0.33) HTR2AHTR2CHTR1ADRD2DRD4
SCHEMBL24916405 0.70 HPGD (0.43) HPGDNPSR1MEN1KMT2AMAPT
SCHEMBL24916406 0.70 HPGD (0.42) HPGDNPSR1MEN1KMT2AMAPT
SCHEMBL24915894 0.69 HTR1A (0.33) HTR2AHTR2CHTR1ADRD2DRD4
SCHEMBL24916057 0.68 HTR1A (0.43) HTR1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 HTR2A 4137/4885HTR2C 3978/4885HTR7 3424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.